Interestingly, when focusing only in men, these three markers (anti-rEiPTP1 IgG, anti-rEiSWP1 IgG, anti-rEiPTP1 IgA) were significantly increased in CRC compared to controls, but were not different between the two female groups (Table 3). This evidence concerns the gene CD79A and colorectal carcinoma.